Trial intelligence / Profile preview

Cyporin for Dry Eye Prevention Before Cataract Surgery

NCT04426240Phase 4Completed

Sponsor
Samsung Medical Center
Start
Aug 2020
Primary completion
Jan 2022
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine in dry eye syndrome (DED), sponsored by Samsung Medical Center. Started Aug 2020; status: completed.

02

Drugs

cyclosporine
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT04426240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04426240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call